TARO 59 (Amiodarone 400 mg)
Pill imprint TARO 59 has been identified as Amiodarone hydrochloride 400 mg.
Amiodarone is used in the treatment of arrhythmia; ventricular tachycardia; ventricular fibrillation; supraventricular tachycardia and belongs to the drug class group III antiarrhythmics. There is positive evidence of human fetal risk during pregnancy. Amiodarone 400 mg is not a controlled substance under the Controlled Substance Act (CSA).
- TARO 59
- 400 mg
- Prescription only
- Drug Class:
- Group III antiarrhythmics
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- Not a controlled drug
- Taro Pharmaceuticals U.S.A., Inc.
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
D&C Yellow No. 10
|NDC Code||Manufacturer / Repackager|
|54569-6129||A-S Medication Solutions, LLC (repackager)|
Note: Inactive ingredients may vary.
More about amiodarone
- Amiodarone injection solution
- Amiodarone injection
- Amiodarone Intravenous (Advanced Reading)
- Amiodarone Intravenous, Oral (Advanced Reading)
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.